280 related articles for article (PubMed ID: 23070603)
1. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
Kaialy W; Nokhodchi A
Pharm Res; 2013 Feb; 30(2):458-77. PubMed ID: 23070603
[TBL] [Abstract][Full Text] [Related]
2. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
Kaialy W; Nokhodchi A
Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318
[TBL] [Abstract][Full Text] [Related]
3. Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.
Kaialy W; Hussain T; Alhalaweh A; Nokhodchi A
Pharm Res; 2014 Jan; 31(1):60-76. PubMed ID: 23918220
[TBL] [Abstract][Full Text] [Related]
4. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R
Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847
[TBL] [Abstract][Full Text] [Related]
5. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
[TBL] [Abstract][Full Text] [Related]
6. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
[TBL] [Abstract][Full Text] [Related]
7. Effect of carrier particle shape on dry powder inhaler performance.
Kaialy W; Alhalaweh A; Velaga SP; Nokhodchi A
Int J Pharm; 2011 Dec; 421(1):12-23. PubMed ID: 21945739
[TBL] [Abstract][Full Text] [Related]
8. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
[TBL] [Abstract][Full Text] [Related]
9. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
10. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
Son YJ; Worth Longest P; Hindle M
Int J Pharm; 2013 Feb; 443(1-2):137-45. PubMed ID: 23313343
[TBL] [Abstract][Full Text] [Related]
11. Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler.
Ferdynand MS; Nokhodchi A
Drug Deliv Transl Res; 2020 Oct; 10(5):1418-1427. PubMed ID: 31933129
[TBL] [Abstract][Full Text] [Related]
12. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
Kaialy W; Momin MN; Ticehurst MD; Murphy J; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Sep; 79(2):345-56. PubMed ID: 20537870
[TBL] [Abstract][Full Text] [Related]
13. Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.
D'Addio SM; Chan JG; Kwok PC; Benson BR; Prud'homme RK; Chan HK
Pharm Res; 2013 Nov; 30(11):2891-901. PubMed ID: 23893019
[TBL] [Abstract][Full Text] [Related]
14. Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.
Littringer EM; Mescher A; Schroettner H; Achelis L; Walzel P; Urbanetz NA
Eur J Pharm Biopharm; 2012 Sep; 82(1):194-204. PubMed ID: 22595133
[TBL] [Abstract][Full Text] [Related]
15. The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.
Kaialy W; Larhrib H; Martin GP; Nokhodchi A
Pharm Res; 2012 Aug; 29(8):2139-56. PubMed ID: 22477070
[TBL] [Abstract][Full Text] [Related]
16. Tribo-Charging Behaviour of Inhalable Mannitol Blends with Salbutamol Sulphate.
Zellnitz S; Pinto JT; Brunsteiner M; Schroettner H; Khinast J; Paudel A
Pharm Res; 2019 Apr; 36(6):80. PubMed ID: 30968221
[TBL] [Abstract][Full Text] [Related]
17. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
[TBL] [Abstract][Full Text] [Related]
18. Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs.
Kaialy W; Nokhodchi A
Int J Pharm; 2013 May; 448(1):58-70. PubMed ID: 23500603
[TBL] [Abstract][Full Text] [Related]
19. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
[TBL] [Abstract][Full Text] [Related]
20. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation.
Arte KS; Tower CW; Mutukuri TT; Chen Y; Patel SM; Munson EJ; Tony Zhou Q
Int J Pharm; 2024 Jan; 650():123698. PubMed ID: 38081559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
